© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86256 refers to the laboratory test that measures the titer of antibodies against noninfectious agents using a fluorescent technique. This procedure is essential for identifying the presence of specific antibodies in a patient's blood sample or cerebral spinal fluid (CSF). The test is typically performed after an initial screening, which is coded under CPT® 86255, to determine if antibodies are present or elevated. The antibodies detected through this testing can indicate various medical conditions or the potential risk of developing certain disorders that are not caused by infectious agents. Examples of such conditions include celiac disease, premature ovarian failure, myasthenia gravis, and other autoimmune disorders. Additionally, this test can help assess exposure to environmental toxins that may lead to autoimmune diseases, certain cancers, graft versus host disease following organ transplants, and myocardial infarction or other forms of cardiac injury. Furthermore, the results from these antibody screenings and titers can serve as valuable markers for monitoring the effectiveness of immunosuppressant therapy in patients undergoing treatment for autoimmune conditions or following transplants.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.